Hiroaki Kanda

5.5k total citations · 1 hit paper
98 papers, 3.9k citations indexed

About

Hiroaki Kanda is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroaki Kanda has authored 98 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 32 papers in Molecular Biology and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroaki Kanda's work include Sarcoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (10 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Hiroaki Kanda is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (10 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Hiroaki Kanda collaborates with scholars based in Japan, United States and Spain. Hiroaki Kanda's co-authors include Yuichi Ishikawa, Seidai Sato, Naoko Ohtani, Eiji Hara, Masahira Hattori, Tze Mun Loo, Kenshiro Oshima, Shin Yoshimoto, Kenya Honda and Yoichiro Iwakura and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Hiroaki Kanda

85 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

2013 1.7k citations Hiroaki Kanda, Seidai Sato et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroaki Kanda Japan	22	2.0k	1.2k	735	699	624	98	3.9k
Woo Sung Moon South Korea	37	1.7k 0.8×	1.5k 1.3×	840 1.1×	786 1.1×	607 1.0×	157	4.6k
Hideki Muramatsu Japan	38	2.5k 1.2×	1.0k 0.9×	621 0.8×	322 0.5×	500 0.8×	274	5.9k
Claudia Goettsch Germany	38	2.0k 1.0×	572 0.5×	578 0.8×	366 0.5×	634 1.0×	77	4.2k
Ilona Kovalszky Hungary	40	2.1k 1.0×	932 0.8×	607 0.8×	703 1.0×	1.0k 1.6×	182	4.8k
Elena Ranieri Italy	41	1.9k 0.9×	1.6k 1.3×	918 1.2×	476 0.7×	620 1.0×	148	5.7k
Nelson H. Tsuno Japan	40	1.7k 0.8×	1.5k 1.3×	445 0.6×	507 0.7×	784 1.3×	168	4.7k
Sohsuke Yamada Japan	30	1.1k 0.5×	647 0.6×	526 0.7×	380 0.5×	295 0.5×	209	3.0k
Angelo Sidoni Italy	32	1.1k 0.5×	1.2k 1.1×	962 1.3×	310 0.4×	712 1.1×	188	3.7k
Takeshi Hisada Japan	33	1.3k 0.6×	985 0.9×	1.3k 1.8×	279 0.4×	378 0.6×	182	3.7k
Adriaan P. de Bruı̈ne Netherlands	43	3.0k 1.4×	1.8k 1.6×	802 1.1×	363 0.5×	911 1.5×	99	5.6k

Countries citing papers authored by Hiroaki Kanda

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kanda more than expected).

Fields of papers citing papers by Hiroaki Kanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kanda. The network helps show where Hiroaki Kanda may publish in the future.

Co-authorship network of co-authors of Hiroaki Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kanda. A scholar is included among the top collaborators of Hiroaki Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kanda. Hiroaki Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saito, Rumiko, Yasuyuki Shigematsu, Manabu Takamatsu, et al.. (2025). Association of Enterotoxigenic Bacteroides fragilis with Immune Modulation in Colorectal Cancer Liver Metastasis. Cancers. 17(17). 2733–2733.

Sugawara, Kotaro, Takashi Fukuda, Chiaki Murakami, et al.. (2024). Impacts of tumor microenvironment during neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma. Cancer Science. 115(8). 2819–2830. 5 indexed citations

Shigematsu, Yasuyuki, Rumiko Saito, Hiroaki Kanda, et al.. (2024). Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence. Cancers. 16(17). 3003–3003. 2 indexed citations

Shigematsu, Yasuyuki, Hiroaki Kanda, Yu Takahashi, et al.. (2023). MHC class I loss is associated with biliary/progenitor cell features and “cold” tumor-immune microenvironment in hepatocellular carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(2). 177–186. 5 indexed citations

Sekiguchi, Yasunobu, Ayumi Gomyo, Nobuo Maseki, et al.. (2023). Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 63(4). 262–265. 1 indexed citations

Suzuki, Sawako, Divya Venkatesh, Hiroaki Kanda, et al.. (2022). GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma. Cancer Research. 82(18). 3209–3222. 108 indexed citations

Shigematsu, Yasuyuki, Hiroaki Kanda, Yu Takahashi, et al.. (2022). Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(2). 253–263. 6 indexed citations

Ishikawa, Ayataka, Junichi Ishii, Hisao Yagishita, et al.. (2022). Stiffness as measured with strain elastography is a prognostic factor for pT1/T2 tongue squamous cell carcinoma with muscle-layer invasion. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 135(4). 558–566. 4 indexed citations

Machinami, Rikuo, Seiichi Matsumoto, Hiroaki Kanda, et al.. (2021). Prognostic value of CD34 expression status in patients with myxofibrosarcomas and undifferentiated pleomorphic sarcomas. Scientific Reports. 11(1). 15494–15494. 4 indexed citations

10.

Shibata, Eri, Midori Shimada, Hiroaki Kanda, et al.. (2020). Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. iScience. 23(7). 101306–101306. 13 indexed citations

11.

Iijima, Moito, Noriyuki Okonogi, Nakako Izumi Nakajima, et al.. (2019). Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma. Journal of Gynecologic Oncology. 31(2). e19–e19. 28 indexed citations

12.

Sugyo, Aya, Atsushi B. Tsuji, Katsuyuki Minegishi, et al.. (2018). α‐particle therapy for synovial sarcoma in the mouse using an astatine‐211‐labeled antibody against frizzled homolog 10. Cancer Science. 109(7). 2302–2309. 30 indexed citations

13.

Sato, Seidai, Akiko Takahashi, Yoshinori Imai, et al.. (2015). Ablation of the p16INK4a tumour suppressor reverses ageing phenotypes of klotho mice. Nature Communications. 6(1). 7035–7035. 60 indexed citations

14.

Kanda, Hiroaki, Reiko Furuta, Noriko Motoi, et al.. (2015). A case of inflammatory hepatocellular adenoma displaying an unusual histological pattern. Clinical Journal of Gastroenterology. 8(6). 426–434. 1 indexed citations

15.

Kanda, Hiroaki, et al.. (2014). Method for Cancer Diagnosis using DNA Ploidy Analysis with a Combination of Fast Fourier Transform and Domain Method. 52(3). 136–144.

16.

Mizuno, Rei, Takashi Akiyoshi, Hiroya Kuroyanagi, et al.. (2011). Intra-abdominal desmoid tumor mimicking locoregional recurrence after colectomy in a patient with sporadic colon cancer: Report of a case. Surgery Today. 41(5). 730–732. 17 indexed citations

17.

Satoh, Yukitoshi, et al.. (2001). Cytology of the lipoma-like type of well-differentiated liposarcoma: diagnosticutility of squash method preparation.. The Journal of the Japanese Society of Clinical Cytology. 40(6). 565–570. 2 indexed citations

18.

Kondo, Yasuko, Tatsuya Izumi, Tatsuo Yanagawa, et al.. (2000). Spontaneously regressed Kaposi’s sarcoma and human herpesvirus 8 infection in a human immunodeficiency virus‐negative patient. Pathology International. 50(4). 340–346. 17 indexed citations

19.

Goto, Akiteru, Hiroaki Kanda, Yuichi Ishikawa, et al.. (1998). Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas. Japanese Journal of Cancer Research. 89(5). 539–547. 44 indexed citations

20.

Ohno, Yoshio, et al.. (1995). RENAL CELL CARCINOMA IN A PATIENT WITH MALIGNANT LYMPHOMA. The Japanese Journal of Urology. 86(2). 341–344. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact